Thymectomy
================
Oscar J. Ponce & Andrea Solis-Pazmino
5/7/2020

## Open Data

> Click any of the following links to view the documents

|        Stage        |                                                                              File                                                                              |
| :-----------------: | :------------------------------------------------------------------------------------------------------------------------------------------------------------: |
|      Protocol       |                                       [Prospero](https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=166827)                                       |
| Abstract screening  | [References used in this stage or search results](https://github.com/ponceoscarj/Thymectomy/blob/master/Screening_results/articles_for_abstract_screening.txt) |
| Full-text screening |          [References used in this stage](https://github.com/ponceoscarj/Thymectomy/blob/master/Screening_results/articles_for_fulltext_screening.txt)          |
|  Included studies   |              [References used for data extraction](https://github.com/ponceoscarj/Thymectomy/blob/master/Screening_results/included_articles.txt)              |
|      Raw data       |                              [Data as `.CSV`](https://github.com/ponceoscarj/Thymectomy/blob/master/Data/thymectomy_outcomes.csv)                              |
|   Analysis codes    |                             [Script as `R Markdown`](https://github.com/ponceoscarj/Thymectomy/blob/master/Thymectomy_results.Rmd)                             |

## Summary of forest plots

**Figure 1** - Summary of forest plots of the risk of achieving Complete
Stable Remission in patients with myasthenia gravis who underwent
**Transsternal thymectomy** vs. those who underwent **Transsternal
thymectomy** at different follow-ups

> To generate this forest plot, we used information from Supplementary
> Figures 1 to 3.

![](Thymectomy_results_files/figure-gfm/unnamed-chunk-1-1.svg)<!-- -->

**Figure 2** - Summary of forest plots of the risk of achieving Complete
Stable Remission in patients with myasthenia gravis who underwent a
**Transsternal Thymectomy** vs. those who underwent a **Minimally
Invasive Thymectomy** at different follow-ups\*\*

> To generate this forest plot, we used information from Supplementary
> Figures 4 to 9.

![](Thymectomy_results_files/figure-gfm/unnamed-chunk-2-1.svg)<!-- -->

**Figure 3** - Summary of forest plots of the risk of achieving Complete
Stable Remission in patients with myasthenia gravis who underwent a
**Minimally Invasive Thymectomy** those who underwent another
**Minimally Invasive Thymectomy** at different follow-ups\*\*
![](Thymectomy_results_files/figure-gfm/unnamed-chunk-3-1.svg)<!-- -->

**Figure 4** - Summary of forest plots of the risk of achieving Complete
Stable Remission in patients with myasthenia gravis who underwent a
**Minimally Invasive Thymectomy** those who underwent another
**Minimally Invasive Thymectomy** at different follow-ups\*\*
![](Thymectomy_results_files/figure-gfm/label_of_this_figure-1.svg)<!-- -->

## Supplementary Figures

### Extended Transsternal vs. Standard Transsternal forest plots

<details>

<summary> Suppl. Figure 1: Extended Transsternal vs. Standard
Transsternal, risk of CSR at 3 years of follow-up </summary>

<p>

![](Thymectomy_results_files/figure-gfm/forestplotma40-1.svg)<!-- -->

</p>

</details>

<details>

<summary> Suppl. Figure 2: Extended Transsternal vs. Standard
Transsternal, risk of CSR at 4 years of follow-up </summary>

<p>

![](Thymectomy_results_files/figure-gfm/forestplotma41-1.svg)<!-- -->

</p>

</details>

<details>

<summary> Suppl. Figure 3: Extended Transsternal vs. Standard
Transsternal, risk of CSR at 4 years of follow-up </summary>

<p>

![](Thymectomy_results_files/figure-gfm/forestplotma42-1.svg)<!-- -->

</p>

</details>

### Extended Transsternal vs. VATS extended forest plots

<details>

<summary> Suppl. Figure 4: Extended Transsternal vs. VATS extended, risk
of CSR at 3 years of follow-up </summary>

<p>

![](Thymectomy_results_files/figure-gfm/forestplotma43-1.svg)<!-- -->

</p>

</details>

<details>

<summary> Suppl. Figure 5: Extended Transsternal vs. VATS extended, risk
of CSR at 4 years of follow-up </summary>

<p>

![](Thymectomy_results_files/figure-gfm/forestplotma44-1.svg)<!-- -->

</p>

</details>

<details>

<summary> Suppl. Figure 6: Extended Transsternal vs. VATS extended, risk
of CSR at 5 years of follow-up </summary>

<p>

![](Thymectomy_results_files/figure-gfm/forestplotma45-1.svg)<!-- -->

</p>

</details>

<details>

<summary> Suppl. Figure 7: Extended Transsternal vs. VATS extended, risk
of CSR at 6 years of follow-up </summary>

<p>

![](Thymectomy_results_files/figure-gfm/forestplotma46-1.svg)<!-- -->

</p>

</details>

<details>

<summary> Suppl. Figure 8: Extended Transsternal vs. VATS extended, risk
of CSR at 7 years of follow-up </summary>

<p>

![](Thymectomy_results_files/figure-gfm/forestplotma47-1.svg)<!-- -->

</p>

</details>

<details>

<summary> Suppl. Figure 9: Extended Transsternal vs. VATS extended, risk
of CSR at 8 years of follow-up </summary>

<p>

![](Thymectomy_results_files/figure-gfm/forestplotma48-1.svg)<!-- -->

</p>

</details>
